What happens to cardiovascular system behind the undetectable level of HIV viremia?
- PMID: 27127532
- PMCID: PMC4848790
- DOI: 10.1186/s12981-016-0105-z
What happens to cardiovascular system behind the undetectable level of HIV viremia?
Abstract
Despite the combined antiretroviral therapy has improved the length and quality of life of HIV infected patients, the survival of these patients is always decreased compared with the general population. This is the consequence of non-infectious illnesses including cardio vascular diseases. In fact large studies have indicated an increased risk of coronary atherosclerotic disease, myocardial infarction even in HIV patients on cART. In HIV infected patients several factors may contribute to the pathogenesis of cardiovascular problems: life-style, metabolic parameters, genetic predisposition, viral factors, immune activation, chronic inflammation and side effects of antiretroviral therapy. The same factors may also contribute to complicate the clinical management of these patients. Therefore, treatment of these non-infectious illnesses in HIV infected population is an emerging challenge for physicians. The purpose of this review is to focus on the new insights in non AIDS-related cardiovascular diseases in patients with suppressed HIV viremia.
Keywords: Cardiovascular diseases; HIV; Premature aging; cARV.
Figures
Similar articles
-
Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.Am J Cardiovasc Drugs. 2011 Dec 1;11(6):383-94. doi: 10.2165/11594590-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 22149317 Review.
-
Management of metabolic complications and cardiovascular risk in HIV-infected patients.AIDS Rev. 2010 Oct-Dec;12(4):231-41. AIDS Rev. 2010. PMID: 21179187 Review.
-
[Arterial hemodynamic parameters and cardiovascular risk in HIV patients with controlled infection].Presse Med. 2018 Jan;47(1):3-10. doi: 10.1016/j.lpm.2017.12.003. Epub 2018 Jan 17. Presse Med. 2018. PMID: 29373278 Review. French.
-
[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Enferm Infecc Microbiol Clin. 2012. PMID: 22633764 Spanish.
-
Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART.Viruses. 2019 Feb 27;11(3):200. doi: 10.3390/v11030200. Viruses. 2019. PMID: 30818749 Free PMC article. Review.
Cited by
-
Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population.J Pers Med. 2021 Oct 25;11(11):1085. doi: 10.3390/jpm11111085. J Pers Med. 2021. PMID: 34834438 Free PMC article.
-
Targeting the HIV-infected brain to improve ischemic stroke outcome.Nat Commun. 2019 May 1;10(1):2009. doi: 10.1038/s41467-019-10046-x. Nat Commun. 2019. PMID: 31043599 Free PMC article.
-
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project.Infect Drug Resist. 2019 May 23;12:1385-1391. doi: 10.2147/IDR.S203813. eCollection 2019. Infect Drug Resist. 2019. PMID: 31213857 Free PMC article.
-
Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.Sci Rep. 2016 Dec 23;6:39738. doi: 10.1038/srep39738. Sci Rep. 2016. PMID: 28008980 Free PMC article.
-
Modelling interaction between HIV-1 Nef and calnexin.AIDS. 2018 Sep 24;32(15):2103-2111. doi: 10.1097/QAD.0000000000001951. AIDS. 2018. PMID: 30005006 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical